Download the Whitepaper

Thank you for your interest in the whitepaper:
High Yield Considerations for Clinical Development in Rare & Genetic Diseases of the Kidney

Read Now >

Learn More About Medpace’s
Nephrology & Renal Disease Capabilities

Medpace has global experience conducting trials for a variety of kidney-related diseases from early through late phase. Our scientifically-driven approach to clinical development provides you the advantage of early and ongoing insight and guidance from therapeutic experts throughout trial design and execution.

You benefit from:

  • In-house board-certified nephrologists with 40+ years of experience in clinical drug development, responsible for leading several drugs from early phase development through product launch
  • Extensive global clinical trial experience in numerous nephrology indications
  • Dedicated nephrology team with a thorough understanding of complex metabolic conditions that cause Chronic Kidney Disease (CKD), as well as the medical complications experienced by CKD and end-stage renal disease (ESRD) patients
  • Well-established international relationships with experienced sites, networks, and KOLs specializing in nephrology
  • A fully integrated solution with our in-house imaging core lab and global central lab to maximize efficiency

Learn more about our capabilities or contact us to connect with our internal experts.